Johnson and Johnson announced that is has reached an agreement to acquire Abbott Medical Optics, a wholly owned subsidiary of Abbott Laboratories, for $4.325 billion in cash.According to a Johnson and Johnson press release, the acquisition will include…
Nearly 16 million Americans are living with vision impairment that is undiagnosed or untreated because eye and vision health lags in priority in the United States, according to a new report from the National Academies of Sciences, Engineering, and Medi…
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Global Ophthalmic Drug & Devices Market, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022” report to their offering. The market for global ophthalmic drugs market was valued around $17,290 million in the year 2015 and is projected to grow with a CAGR of around 7% during the forecast period of 2016-2022. The global ophthalmic drugs market is set to display a stable growth during 2016-2022 period whi
COPENHAGEN — At the European Society of Cataract and Refractive Surgeons meeting, Farhad Hafezi, MD, PhD, talks about PACK cross-linking, a new modality of using cross-linking for the treatment of infectious keratitis. He also introduces a newly patented technology that allows the performance of cross-linking — for both keratoconus and corneal infection — at the slit lamp, no longer in the OR but in the office.
In a study published online by JAMA Ophthalmology, Changwen Ke, Ph.D., of the Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China and colleagues examined whether Zika…
COPENHAGEN — At the European Society of Cataract and Refractive Surgeons meeting here, Bret Fisher, MD, discusses a study he performed on 40 eyes comparing the “dropless” cataract surgery injection regimen to the “less drops” regimen. The study found the main difference between the two regimens was a significant patient preference for the “dropless” regimen over the “less drops” one.